BBOT
BridgeBio Oncology Therapeutics, Inc.
Recent 8-K filings for BBOT
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 21:07 UTC earnings item 2.02item 9.01
BBOT Q1 net loss widens to $42.1M; cash $388.9M funds ops into 2028; pipeline shows early efficacy
source · BBOT on sec.gov